
Antibióticos Naturais e Semissintéticos
Os antibióticos naturais e semissintéticos são caracterizados por estruturas químicas com anéis heterocíclicos e grupos funcionais ativos que inibem o crescimento de microrganismos. Suas estruturas permitem-lhes interagir com os processos vitais das bactérias, tornando-os úteis para o tratamento de infecções bacterianas. Os antibióticos semissintéticos podem ser modificados para melhorar o espectro de atividade ou a resistência à degradação.
Na CymitQuimica, oferecemos antibióticos naturais e semissintéticos de alta qualidade para pesquisa em microbiologia e desenvolvimento farmacêutico.
Foram encontrados 6376 produtos de "Antibióticos Naturais e Semissintéticos"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Erythromycin Glucoheptonate
CAS:Produto Controlado<p>Applications Erythromycin Glucoheptonate is a derivative of Erythromycin (E649950), an antibiotic.<br>References Delaforge, M. et al.: Biochem. Pharm., 32, 2309 (1983); Niederau, W. et al.: Chemother., 26, 121 (1980);<br></p>Fórmula:C37H67NO13·C7H14O8Cor e Forma:NeatPeso molecular:960.11(S)-N-(3-((3-Fluoro-4-morpholinophenyl)amino)-2-hydroxypropyl)acetamide
CAS:Produto ControladoFórmula:C15H22FN3O3Cor e Forma:NeatPeso molecular:311.351,3’’-Di-HABA Kanamycin A Sulfate
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications Kanamycin (K137500) derivative as synthetic byproduct of Amikacin (A578500).<br>References Kawaguchi, H., et al.: J. Antibiotics, 25, 695 (1972), Naito, T., et al.: J. Antibiotics, 26, 297 (1973),<br></p>Fórmula:C26H50N6O15xH2SO4Cor e Forma:NeatPeso molecular:686.71Tigecycline Ethylmethylamino Analogue
Produto ControladoFórmula:C30H41N5O8Cor e Forma:NeatPeso molecular:599.675N-Nitroso Linezolid Impurity
Produto ControladoFórmula:C15H21FN4O4Cor e Forma:NeatPeso molecular:340.36Cefixime Acid, Thiazine Isomer Impurity Sodium Salt (>80%)
CAS:<p>Stability Very unstable<br>Applications Cefixime Impurity is an impurity of Cefixime (C242800); an orally active third generation cephalosporin antibiotic.<br>References Kamimura, T., et al.: Antimicrob. Agents Chemother., 25, 98 (1984); Yamanaka, H., et al.: J. Antibiot., 38, 1738 (1985); Guay, D.R.P., et al.: Antimicrob. Agents Chemother., 30, 485 (1986)<br></p>Fórmula:C16H17N5O8S2·x(Na)Pureza:>80%Cor e Forma:NeatPeso molecular:471.46 + x(22.99)2,6-Diamino-2,3,6-trideoxy-D-ribo-Hexose Di-TFA Salt
CAS:Produto Controlado<p>Applications Di-TFA Salt of 2,6-Diamino-2,3,6-trideoxy-D-ribo-Hexose is a degradent of Tobramycin (T524000) a single factor antibiotic comprising about 10% of nebramycin, the aminoglycosidic antibiotic complex produced by Streptomyces tenebrarius. Antibacterial.<br>References Koch, K.F., et al.: Antimicrob. Agents Chemother., 309 (1970), Welles, J.S., et al.: Toxicol. Appl. Pharmacol., 22, 332 (1972), Dash, A.K., et al.: Anal. Profiles Drug Subs. Excip., 24, 579 (1996),<br></p>Fórmula:C6H14N2O3•2(C2HF3O2)Cor e Forma:NeatPeso molecular:162.19211402N-Acetyl Cefixime
<p>Applications N-Acetyl Cefixime is the N-acetylated analogue and impurity of the third generation cephalosporin antibiotic, Cefixime (C242800).<br></p>Fórmula:C18H17N5O8S2Cor e Forma:NeatPeso molecular:495.49ent-Moxifloxacin Hydrochloride
CAS:Produto ControladoFórmula:C21H25ClFN3O4Cor e Forma:NeatPeso molecular:437.89Amoxicillin sodium (Amox)
CAS:Produto Controlado<p>Applications Amoxicillin sodium (Amox) (cas# 34642-77-8) is a useful research chemical.<br></p>Fórmula:C16H18N3O5S·NaCor e Forma:White PowderPeso molecular:387.396,11-Di-O-methyl Erythromycin
CAS:Produto Controlado<p>Impurity Clarithromycin EP Impurity E<br>Applications 6,11-Di-O-methyl Erythromycin (Clarithromycin EP Impurity E) is a Di-O-alkyl Erythromycin (E649950) is an impurity of Clarithromycin (C559750). Clarithromycin impurity E per British Pharmacopoeia.<br>References Morimoto, S. et al.: J. Antibiot., 43, 286 (1990); Kohno, Y. et al.: J. Antimicrob. Chemother., 26, 503 (1990);<br></p>Fórmula:C39H71NO13Cor e Forma:White To Off-WhitePeso molecular:761.984-Epianhydrotetracycline Hydrochloride Hydrate (>85%)
CAS:Produto Controlado<p>Applications An antibiotic derived from Tetracycline. Studies have shown that this derivative can have a 250-fold higher toxicity depending on the system under study. This compound is a contaminant of emerging concern (CECs).<br>References Simmons, D., et al.: J. Pharm. Sci., 55, 1313 (1966), Paemen, L., et al.: Biochem. Pharmacol., 52, 105 (1996),<br></p>Fórmula:C22H22N2O7·HCl·H2OPureza:>85%Cor e Forma:NeatPeso molecular:462.88(6R,7S)-Cefoperazone Sodium Salt
CAS:<p>Applications (6R,7S)-Cefoperazone Sodium Salt is the enantiomer of Cefoperazone (C242900) as an impurity.<br>References Fabre, H., et al.: J. Pharm. Sci., 73, 611 (1984), Strasters, J., et al.: Anal. Chem., 63, 2503 (1991), Chen, Z., et al.: World Notes Antibiot., 25, 249 (2004),<br></p>Fórmula:C25H26N9O8S2·NaCor e Forma:NeatPeso molecular:667.6492Linezolid Dimer
CAS:<p>Applications Linezolid Dimer is an impurity of the antibacterial agent Linezolid (L466500).<br></p>Fórmula:C30H35F2N5O7Cor e Forma:NeatPeso molecular:615.621-Hydroxy-2,7-diamino Mitosene (Mixture cis/trans)
CAS:Produto Controlado<p>Applications Mitomycin (M371900) impurity.<br>References Siegel, D., et al.: Biochemistry, 31, 7879 (1992), Kontou, M., et al.: Oncogene, 21, 2406 (2002),<br></p>Fórmula:C14H16N4O5Cor e Forma:NeatPeso molecular:320.30cis-Terbinafine Hydrochloride
CAS:Produto Controlado<p>Impurity Terbinafine EP Impurity B<br>Applications cis-Terbinafine Hydrochloride (Terbinafine EP Impurity B) is an impurity in the production of Terbinafine hydrochloride.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Petranyi, G., et al.: Science, 224, 1239 (1984), Stutz, A., et al.: J. Med. Chem., 27, 1539 (1984),<br></p>Fórmula:C21H25N·ClHCor e Forma:WhitePeso molecular:327.89cis-1-Hydroxy-2,7-diamino Mitosene
CAS:Produto Controlado<p>Applications cis-1-Hydroxy-2,7-diamino Mitosene is derived from Mitomycin C (M371900), which is an antitumor antibiotic. It is antineoplastic. Also, it is an oxazolidinone derivative resulting from a cyclization reaction of bicarbonate with the aziridine ring of aziridinomitosene.<br>References Kinoshita, S., et al.: J. Med. Chem., 14, 13 (1971); Beijnen, J.H., et al.: Anal. Profiles Drug Subs., 16, 361 (1986); Paz, M. M.: Bioorg. Med. Chem. Lett., 20, 31-34 (2010)<br></p>Fórmula:C14H16N4O5Cor e Forma:NeatPeso molecular:320.30Di-2-(Hydroxyphenyl)acetamido Cefprozil (Mixture of E/Z isomers)
Produto Controlado<p>Stability Light Sensitive<br>Applications Di-2-(Hydroxyphenyl)acetamido Cefprozil is an impurity in the synthesis of Cefprozil (C243910), semisynthetic oral cephalosporin consisting of approx. 90:10 Z/E isomeric mixture. Antibacterial.<br>References Jones, R.N., et al.: Diagn. Microb. Infect. Dis., 9, 11 (1988), Barbhaiya, R.H., et al.: Antimicrob. Agents Chemother., 34, 1204 (1990)<br></p>Fórmula:C26H26N4O7SCor e Forma:NeatPeso molecular:538.57N-t-Butyl Linezolid
CAS:Produto Controlado<p>Applications N-t-Butyl Linezolid is a derivative of Linezolid (L466500), prototype of the oxazolidinone antimicrobials; inhibits bacterial mRNA translation.<br>References Brickner, S.J., et al.: J. Med. Chem., 39, 673 (1996), Ford, C.W., et al.: Antimicrob. Agents Chemother., 40, 1508 (1996), Rybak, M.J., et al.: Pharmacotherapy, 18, 456 (1998), Stevens, D.L., et al.: Clin. Infect. Dis., 34, 1481 (2002),<br></p>Fórmula:C20H28FN3O4Cor e Forma:NeatPeso molecular:393.45δ2-Cefadroxil
CAS:<p>Stability Light and Temperature Sensitive<br>Applications Δ2-Cefadroxil is a derivative of Cefadroxil (C235750), a semi-synthetic cephalosporin antibiotic. Antibacterial.<br>References Buck, R.E., et al.: Antimicrob. Agents Chemother., 11, 324 (1977)<br></p>Fórmula:C16H17N3O5SCor e Forma:Off White SolidPeso molecular:363.39S-Nitroso-N-acetyl-D,L-penicillamine
CAS:Produto Controlado<p>Applications Produced concentration-related relaxations of mouse anococcygeus, in a range similar to that already found for NO and other nitrovasodilators. A potent relaxant of non-vascular smooth muscle. Serves as an NO donor.<br>References Bauer & Fung: J. Pharmacol. Exp. Ther., 256, 249 (1991), Gibson, A., et al.: Brit. J. Pharm., 107, 715 (1992), Shaffer, et al.: J. Pharm. Exper. Ther., 260, 286 (1992), Jansen, A., et al.: J. Pharmacol. Exp. Ther., 261, 154 (1992), Lander, H.M. et al.: J. Immunol., 150, 1509 (1993)<br></p>Fórmula:C7H12N2O4SCor e Forma:Green SolidPeso molecular:220.25N-[(2E)-6,6-Dimethyl-2-hepten-4-yn-1-yl]-N,4-dimethyl-1-naphthalenemethanamine Hydrochloride
CAS:Produto Controlado<p>Impurity Terbinafine EP Impurity D; Terbinafine USP Related Compound D; Terbinafine BP Impurity D<br>Applications N-[(2E)-6,6-dimethyl-2-hepten-4-yn-1-yl]-N,4-dimethyl-1-naphthalenemethanamine (Terbinafine EP Impurity D; Terbinafine USP Related Compound D; Terbinafine BP Impurity D) is an impurity of Terbinafine (T107500), an orally active, antimycotic allylamine and a specific inhibitor of squalene epoxidase.<br>References Petranyi, G., et al.: Science, 224, 1239 (1984); Ryder, N.S., et al.: Antimicrob. Agents Chemother., 27, 252 (1985); Evans, E.G.V., et al.: Br. Med. J., 318, 1031 (1999);<br></p>Fórmula:C22H27N·ClHCor e Forma:NeatPeso molecular:341.917p-Nitrobenzyl 6-(1’-Hydroxyethyl)-azabicyclo(3.2.0)heptane-3,7-dione-2-carboxylate
CAS:Produto Controlado<p>Applications Imipenem intermediate.<br></p>Fórmula:C16H16N2O7Cor e Forma:NeatPeso molecular:348.31Ampicillin Desoxocarboxylic Acid-[(R)-Phenylglycine]
CAS:Produto ControladoFórmula:C24H26N4O5SCor e Forma:NeatPeso molecular:482.55Tacrolimus Methyl Acryl Aldehyde
CAS:Produto Controlado<p>Impurity Tacrolimus Methylacryl Aldehyde (USP)<br>Applications Tacrolimus Methyl Acryl Aldehyde is the degradation product of Tacrolimus (F370000), a novel macrocyclic lactone isolated from Streptomyces tsukubaensis, having immunosuppressant activity.<br>References Asano, K., et al.: In Vivo, 10, 537 (1996), McCall, E., et al.: Circ. Res., 79, 1110 (1996), Raufman, J.P., et al.: J. Biol. Chem., 271, 19877 (1996), Rokaw, M.D., et al.: Am. J. Physiol., 271, C194 (1996), Knoll, G.A., and Bell, R.C.: Brit. Med. J., 318, 1104 (1999),<br></p>Fórmula:C11H18O3Cor e Forma:NeatPeso molecular:198.26tert-Butyl N-[2-[2-(6-chlorohexyloxy)ethoxy]ethyl]carbamate
CAS:Produto Controlado<p>Applications tert-Butyl N-[2-[2-(6-chlorohexyloxy)ethoxy]ethyl]carbamate is an intermediate in the synthesis of HaloTag O2 Tobramycin (H103850). HaloTag O2 Tobramycin is a derivative compound of Tobramycin (T524000), a single factor antibiotic comprising about 10% of nebramycin, the aminoglycosidic antibiotic complex produced by Streptomyces tenebrarius. An Antibacterial.<br>References Koch, K.F., et al.: Antimicrob. Agents Chemother., 309 (1970); Welles, J.S., et al.: Toxicol. Appl. Pharmacol., 22, 332 (1972); Dash, A.K., et al.: Anal. Profiles Drug Subs. Excip., 24, 579 (1996)<br></p>Fórmula:C15H30ClNO4Cor e Forma:NeatPeso molecular:323.86tert-Octylamine
CAS:Produto Controlado<p>Impurity Potassium Clavulanate EP Impurity K<br>Applications tert-Octylamine (Potassium Clavulanate EP Impurity K) is used in the synthesis of aminomethyltetracycline dericatives as novel antibacterial agents. Also used in the preparation of carbonyl or sulfonylpyrrolidine containing uracil derivatives which have potent effect in the inhibitoon of deoxyuridine triphosphatase inhibitors.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Clark, R. et al.: J. Med. Chem., 56, 8112 (2013); Miyakoshi, H. et al.: J. Med. Chem., 55, 2960 (2012);<br></p>Fórmula:C8H19NCor e Forma:NeatPeso molecular:129.24S-Decyanomethyl-S-(1-methyl-1H-tetrazol-5-yl) Cefmetazole Sodium Salt
CAS:Produto ControladoFórmula:C15H17N10NaO5S3Cor e Forma:NeatPeso molecular:536.54Amino(3-chlorophenyl)acetic Acid
CAS:Produto Controlado<p>Applications Amino(3-chlorophenyl)acetic Acid functions as intermediate useful in the preparation of synthetic penicillins, also used in the structure-activity relationship examination of several drugs containing the benzyl moiety, their roles in biochemical and pharmacological processes.<br>References Hansch, C., et al.: J. Med. Chem., 13, 957 (1970); Holdrege, C. T., et al.: Can. (1975), CA 966853 A2 19750429;<br></p>Fórmula:C8H8ClNO2Cor e Forma:NeatPeso molecular:185.612’-Tosyloxy-dihydropleuromutilin
CAS:Produto Controlado<p>Applications Intermediate in the preparation of Azamulin<br></p>Fórmula:C29H42O7SCor e Forma:NeatPeso molecular:534.706-O-[3-Acetamido-3-deoxy-a-D-glucopyranosyl]-4-O-(6-acetamido-3,6-dideoxy-3-nitrohexopyranosyl)-N,N’-diacetyl-2-deoxy-D-streptamine
CAS:Produto Controlado<p>Applications Kanamycin A (K137500) derivative.<br></p>Fórmula:C26H43N5O16Cor e Forma:NeatPeso molecular:681.642-(Diethylamino)ethanethiol
CAS:Produto ControladoFórmula:C6H15NSCor e Forma:NeatPeso molecular:133.261-(4-Aza-8-hydroxy-6-oxo)oct-2-en-1-oylimidazole-d3 (mixture E/Z)
CAS:Produto Controlado<p>Applications Clavulanic acid (C563750) impurity as a alkaline degradation product.<br>References Haginaka, J., et al.: Chem. Pharm. Bull., 31, 4436 (1983),<br></p>Fórmula:C10D3H10N3O3Cor e Forma:NeatPeso molecular:226.25Erythrolosamine
CAS:Produto Controlado<p>Applications Erythrolosamine is a derivative of Erythromycin A Oxime (E650010), which displays no antibacterial activity. It is a potent precursor of ketolide antibiotics.<br>References Basnet, D. et al.: J. Biotech., 135, 92 (2008); LeMahieu, R. et al.: J. Med. Chem., 17, 953 (1974)<br></p>Fórmula:C29H53NO10Cor e Forma:NeatPeso molecular:575.733-Methyl-2,5-bis-(2-hydroxyethyl)pyrazine
CAS:Produto Controlado<p>Applications 3-Methyl-2,5-bis-(2-hydroxyethyl)pyrazine is a degradation product of Clavulanic Acid (C563750), a β-lactamase inhibitor, typically added to amoxicillin to increase its effectiveness.<br>References Reading, C. and Cole, M.: Antimicrob. Ag. Chemother., 11, 852 (1977), Ball, A.P., et al.: Lancet, 1, 620 (1980), Brogden, R.N., et al. Drugs, 22, 337 (1981); Haginaka, J. et al.: Chem. Pharm. Bull., 33, 218 (1985);<br></p>Fórmula:C9H14N2O2Cor e Forma:NeatPeso molecular:182.22N-Ethoxycarbonyl 7-ADCA
CAS:Produto Controlado<p>Applications A derivative of 7-Aminodeacetylcephalosporanic Acid (A604330) derivative with bactericidal properties. Used in the preparation of penicillin and deacetylcephaphosphorin derivatives.<br>References Borowicz, P. et al.: Pol. J. Pharmacol. Pharm., 31, 227 (1979);<br></p>Fórmula:C11H14N2O5SCor e Forma:NeatPeso molecular:286.3Ixabepilone
CAS:Produto Controlado<p>Applications Ixabepilone is an anti-tumor agent used in the treatment of patients suffering from solid tumors, such as metastatic breast cancer.<br>References Duska, L. et al.: Gynecol. Oncol., 135, 44 (2014); Deeken, J. et al.: Cancer Chemother. Pharmacol., 73, 1071 (2014);<br></p>Fórmula:C27H42N2O5SCor e Forma:NeatPeso molecular:506.70Cefixime Ethyl Ester Sodium Salt (Cefixime EP Impurity F)
CAS:Produto Controlado<p>Impurity Cefixime EP Impurity F<br>Applications Cefixime Ethyl Ester is an ester impurity of the third generation cephalosporin antibiotic, Cefixime (C242800).<br>References Bian, L. et al.: Yao. Fen. Zaz., 30, 872 (2010);<br></p>Fórmula:C18H18N5NaO7S2Cor e Forma:NeatPeso molecular:503.48Ciprofloxacin Lactate
CAS:Produto Controlado<p>Applications Ciprofloxacin Lactate is an antibiotic that has been used to medicate polymer wound dressing. Ciprofloxacin Lactate has been shown to produce high and sustained serum bactericidal titers against highly susceptible bacteria.<br>References Yu, H., et. al.: J. Appl. Polymer Sci., 101, 2453 (2006); Dudley, M.N., et. al.: DICP, Annals, Pharmacotherapy, 23, 456 (1989)<br></p>Fórmula:C17H18FN3O3·C3H6O3Cor e Forma:NeatPeso molecular:421.42Streptidine Dihydrochloride
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications Streptidine is a metabolite derivative of Streptomycin (S687500), an antibiotic (antimycobacterial) drug, used for patients suffering from tuberculosis or other infectious diseases.<br>References Granados, O., et al.: Histology and Histopathology, 20, 357 (2005)<br></p>Fórmula:C8H20Cl2N6O4Cor e Forma:NeatPeso molecular:335.19Ceftazidime Methyl Ester (>85%)
CAS:Produto Controlado<p>Impurity Ceftazidime EP Impurity H<br>Applications Ceftazidime Methyl Ester (Ceftazidime EP Impurity H) is an impurity of Ceftazidime (C244100). Ceftazidime impurity G.<br>References Miyake, A., et al.: Antimicrob. Agents Chemother., 486, 182 (1989), Seibert, G., et al.: Arzneim.-Forsch., 33, 1084 (1983),<br></p>Fórmula:C23H24N6O7S2Pureza:>85%Cor e Forma:NeatPeso molecular:560.602,5-Anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-(hydroxymethyl)-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol
CAS:Produto Controlado<p>Impurity Posaconazole Impurity;<br>Applications 2,5-Anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-(hydroxymethyl)-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol is building block to synthesize key intermediates towards synthesis of highly active azole antifungals Sch 51048, Sch 56592 and Sch 45012. It is also an impurity/intermediate for posaconazole (P689600).<br>References Saksena, A., et al.: Tetrahedron Lett., 37, 5657 (1996); Lovey, R., et al.: Tetrahedron Lett., 35, 6047 (1994); Saksena, A., et al.: Tetrahedron Lett., 36, 1787 (1995)<br></p>Fórmula:C14H15F2N3O2Cor e Forma:NeatPeso molecular:295.284-[4-(4-O-Methoxymethyl-4-hydroxyphenyl)-1-piperazinyl]phenyl]carbamic Acid-d4 Phenyl Ester
CAS:Produto Controlado<p>Applications Intermediate in the production of labelled Posaconazole.<br></p>Fórmula:C25H23D4N3O4Cor e Forma:NeatPeso molecular:437.52Clarithromycin (9Z)-O-Methyloxime
CAS:Produto Controlado<p>Impurity Clarithromycin Impurity O EP<br>Stability Hygroscopic<br>Applications Clarithromycin (9Z)-O-Methyloxime is an impurity of Clarithromycin (C559750); a semi-synthetic macrolide antibiotic and derivative of Erythromycin (E650000).<br>References Morgan, D., et al.: J. Chromatogr., 502, 351 (1990); Benson, C., et al.: Eur. J. Clin. Microbiol., 6, 173 (1987); Boyanova, L., et al.: J. Med. Microb., 61, 85 (2012); Lin, Z., et al.: Toxicol. Sci., 126, 114 (2012)<br></p>Fórmula:C39H72N2O13Cor e Forma:Beige SolidPeso molecular:776.997-Amino-3-cephem-4-carboxylic Acid
CAS:Produto Controlado<p>Applications Reagent used in the preparation of Cephalosporin antibiotics.<br>References Choi, K., et al.: J. Antibiotics, 50, 279 (1997), Bharathi, C., et al.: J. Pharm. Biomed. Anal., 43, 733 (2007),<br></p>Fórmula:C7H8N2O3SCor e Forma:NeatPeso molecular:200.22N-Methyl Gatifloxacin-d3
CAS:Produto Controlado<p>Applications A labelled impurity of Gatifloxacin.<br>References Naber, C., et al.: Antimicrob. Agents Chemother., 45, 293 (2001), Herzler, M., et al.: J. Anal. Toxicol., 27, 233(2003), Pragst, F., et al.: Clin. Chem. Lab. Med., 42, 1325 (2004),<br></p>Fórmula:C20H21D3FN3O4Cor e Forma:NeatPeso molecular:392.44(Z)-7-(((2R)-2-Carboxy-2-((4-oxopentan-2-yl)amino)ethyl)thio)-2-((S)-2,2-dimethylcyclopropanecarboxamido)hept-2-enoic Acid (>90%)
Produto Controlado<p>Applications (Z)-7-(((2R)-2-Carboxy-2-((4-oxopentan-2-yl)amino)ethyl)thio)-2-((S)-2,2-dimethylcyclopropanecarboxamido)hept-2-enoic Acid is an impurity of Cilastatin (C441100), prevents renal metabolism of penem and carbapenem antibiotics by specific and reversible dehydropeptidase I inhibition. Antibacterial adjunct.<br>References Finlay, K.R., et al.: Invest. Ophthalmol. Visual Sci., 24, 1147 (1983), Norrby, S.R., et al.: Antimicrob. Agents Chemother., 23, 300 (1983), Washburn, D.E., et al.: J. Antimicrob. Chemother., 12, 39 (1983),<br></p>Fórmula:C21H34N2O6SPureza:>90%Cor e Forma:NeatPeso molecular:442.57E-Ceftazidime
CAS:Produto Controlado<p>Applications E-Ceftazidime is an impurity of Ceftazidime Pentahydrate (C244100); which is a third generation cephalosporin antibiotic.<br>References Brodie, A., et al.: Antimicrob. Agents Chemother., 17, 876 (1980); Richards, D.M., et al.: Drugs, 29, 105 (1985); Abounassif, M.A., et al.: Anal. Profiles Drug Subs., 19, 95 (1990)<br></p>Fórmula:C22H22N6O7S2Cor e Forma:NeatPeso molecular:546.58
